Home · Learn · The cosmetic peptide landscape

Guide No. 13 of 25

The cosmetic peptide landscape.

A research overview of the cosmetic peptide family , signal peptides, expression line peptides, carrier peptides, neurotransmitter inhibiting peptides , and how the major Apothify entries fit together.

01 /What cosmetic peptides are

Cosmetic peptides are short synthetic peptides developed primarily for topical use in cosmetic research. The category is well established in the personal care industry and most of the commonly studied compounds have an International Nomenclature of Cosmetic Ingredients (INCI) name in the format Peptide NN or Acetyl Peptide NN or descriptive names like Argireline and Matrixyl.

Within the research peptide library category, cosmetic peptides occupy a particular niche: they are typically SAFE (no FDA action history because they have not been positioned as pharmaceutical compounds), they are relatively inexpensive per milligram, and the published literature focuses on dermal matrix proteins, melanocyte signaling, fibroblast biology, and skin barrier function.

02 /Four families to know

Signal peptides act as messenger molecules that trigger fibroblast collagen synthesis or other dermal matrix responses. The canonical examples are Matrixyl (palmitoyl pentapeptide 4 or Pal-KTTKS), Hexapeptide-9, Tripeptide-29, and the related signal peptide family.

Carrier peptides deliver trace elements (typically copper) to enzymatic targets. GHK-Cu is the canonical copper carrier; AHK-Cu is a related copper tripeptide commonly studied in hair research contexts.

Neurotransmitter inhibiting peptides (expression line peptides) modulate neuromuscular junction signaling at the SNARE complex or postsynaptic acetylcholine receptors. Argireline (Acetyl Hexapeptide-3 or Acetyl Hexapeptide-8 in some naming systems) is the canonical entry; SNAP-8, Acetyl Hexapeptide-30, Pentapeptide-3 (Vialox), and Tripeptide-3 are sister compounds.

Enzyme inhibiting peptides modulate skin biology by inhibiting specific enzymes. Eyeseryl (acetyl tetrapeptide-5) targets enzymes related to periorbital pigmentation; Decapeptide-12 (Lumixyl) is a tyrosinase inhibitor in pigmentation research.

03 /The Apothify cosmetic shelf

The skin and hair research category in the Apothify library covers the major cosmetic peptides: Argireline, Matrixyl, SNAP-8, Acetyl Tetrapeptide-3, Eyeseryl, Pal-KTTKS, Pal-GHK, GHK, GHK-Cu, AHK-Cu, Acetyl Hexapeptide-30, Decapeptide-12, Hexapeptide-11, Tripeptide-29, Pentapeptide-3 (Vialox), Tripeptide-3, and Hexapeptide-9.

Most are SAFE with warning level 1. They are sold as aqueous solutions (typically 10 milliliter vials for topical research use) or as lyophilized powders for laboratory work.

04 /Interaction rules in the cosmetic family

Expression line peptides overlap heavily and the Apothify interaction matrix flags several as redundant: Argireline plus Acetyl Hexapeptide-30, Argireline plus Pentapeptide-3, Argireline plus Tripeptide-3, and SNAP-8 plus Acetyl Hexapeptide-30 all carry redundant flags.

Collagen signal peptides are flagged as synergy when stacked: Matrixyl plus Hexapeptide-9 and Matrixyl plus Tripeptide-29 both carry synergy flags. Hexapeptide-11 plus Matrixyl is flagged as synergy where fermentation derived peptides pair with signal peptides in dermal matrix research.

Decapeptide-12 plus GHK-Cu is flagged as synergy in pigmentation pathway plus copper carrier pairings.

05 /Sources of confusion

Naming is inconsistent. Argireline is sometimes labeled Acetyl Hexapeptide-3 (older INCI) and sometimes Acetyl Hexapeptide-8 (newer INCI); the molecule is the same. Matrixyl is sometimes labeled Palmitoyl Pentapeptide-3 or Pal-KTTKS; same molecule under different conventions.

Cosmetic claims in marketing copy can be aggressive. The Apothify entries use research framing only; the actual published research describes activity in cellular and dermal matrix models, not finished cosmetic product performance.

06 /How to pick a starting point

For collagen and dermal matrix research, the cleanest starting point is Matrixyl (Pal-KTTKS), with Hexapeptide-9 or Tripeptide-29 as sister compounds for signal peptide research.

For expression line research, Argireline is the canonical entry. SNAP-8 and Acetyl Hexapeptide-30 are the most commonly compared alternatives.

For copper peptide research, GHK is the foundational sequence with GHK-Cu as the most commonly studied salt form. AHK-Cu is the hair research analog.

For pigmentation research, Decapeptide-12 (Lumixyl) and Eyeseryl are the two most commonly studied entries.

07 /Research notes specific to cosmetic peptides

Most cosmetic peptides are stable at room temperature in their aqueous solution form for weeks to months. Refrigeration extends stability further. Lyophilized form is stable for years at room temperature.

Aqueous solutions are typically 10 millimolar or 1 percent by weight. Concentration choice depends on the experimental model; higher concentrations are not necessarily better and may introduce solubility issues with some sequences.

Many cosmetic peptides have associated patents at the formulation level; the underlying sequences are typically not novel enough to support composition of matter patents. This means generic suppliers can synthesize the sequences freely and prices have collapsed over the past decade.

08 /Where the literature is going

Active research areas include the cross category overlap between cosmetic peptides and broader dermal matrix research, the role of specific copper coordination chemistry in tissue research, and the mechanism of newer signal peptides (Decapeptide-12, Hexapeptide-11) compared with the older generation (Matrixyl, Pal-KTTKS).

The Apothify entries summarize the published research and link to related peptides via the compare tool. For sequence specific synthesis questions, manufacturers are the right contact.